Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPV117059: A Long-Term Extension Study of Ofatumumab Injection for Subcutaneous Use in Subjects With Pemphigus Vulgaris

NCT02613910 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02613910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02613910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPV117059: A Long-Term Extension Study of Ofatumumab Injection for Subcutaneous Use in Subjects With Pemphigus Vulgaris
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
December 23, 2015
Completion date
March 23, 2016
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pemphigus